Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2023

Mar 28, 2023

30339_dirs_2023-03-28_1704405f-58c7-4a2c-88f1-735574eff79f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-12-31

Reporting Person: Green Eric Mark (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-10 Common Stock G 2700.00 $371.47 Disposed 125874.0865 Direct

Footnotes

F1: This transaction represents a charitable gift donation to a private, non-profit educational institution for which Mr. Green received no compensatory benefit and subject to the requirement that the shares were not sold for 60 days by the recipient